BEIJING, Feb. 22, 2019 /PRNewswire/ — The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt® (fully human anti-PD-1 therapeutic monoclonal antibody, generic name: sintilimab injection), hosted by Innovent Biologics, Inc….

View more at https://www.prnewswire.com:443/news-releases/innovent-organized-a-forum-discussing-the-pending-launch-of-its-anti-pd-1-tyvyt-sintilimab-injection-as-part-of-the-national-mega-innovation-program-in-beijing-300800243.html